The FBR & Co Analysts Give CytRx Corp. (CYTR) a $3.00 Price Target

The FBR & Co Analysts Give CytRx Corp. (CYTR) a $3.00 Price Target

FBR & Co set a $3.00 price target on CytRx Corp. (NASDAQ:CYTR) in a report issued on Monday. The firm currently has a a buy rating on the stock.

Several other equities research analysts have also recently commented on CYTR. Zacks Investment Research cut shares of CytRx Corp. from a buy rating to a hold rating in a research report on Tuesday, July 12th. S&P Equity Research decreased their price objective on shares of CytRx Corp. from $1.04 to $0.75 in a report on Tuesday, July 12th. Finally, Jefferies Group restated a hold rating and set a $0.75 price objective (down previously from $2.50) on shares of CytRx Corp. in a report on Friday, July 15th. One analyst has rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The stock currently has an average rating of Buy and an average target price of $5.32.

CytRx Corp. (NASDAQ:CYTR) opened at 0.4864 on Monday. The firm’s market cap is $47.15 million. The stock’s 50 day moving average is $0.57 and its 200 day moving average is $1.71. CytRx Corp. has a 52 week low of $0.48 and a 52 week high of $3.66.

CytRx Corp. (NASDAQ:CYTR) last issued its quarterly earnings results on Friday, July 29th. The company reported ($0.27) EPS for the quarter, missing the consensus estimate of ($0.19) by $0.08. Equities research analysts expect that CytRx Corp. will post ($0.71) EPS for the current year.

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Vanguard Group Inc. boosted its position in shares of CytRx Corp. by 6.7% in the second quarter. Vanguard Group Inc. now owns 2,242,710 shares of the company’s stock worth $5,001,000 after buying an additional 141,544 shares in the last quarter. BlackRock Fund Advisors raised its position in shares of CytRx Corp. by 0.8% in the second quarter. BlackRock Fund Advisors now owns 1,733,219 shares of the company’s stock worth $3,865,000 after buying an additional 13,852 shares during the last quarter. BlackRock Institutional Trust Company N.A. raised its position in shares of CytRx Corp. by 1.2% in the second quarter. BlackRock Institutional Trust Company N.A. now owns 1,653,383 shares of the company’s stock worth $3,687,000 after buying an additional 19,859 shares during the last quarter. State Street Corp raised its position in shares of CytRx Corp. by 1.4% in the second quarter. State Street Corp now owns 945,779 shares of the company’s stock worth $2,106,000 after buying an additional 12,877 shares during the last quarter. Finally, Geode Capital Management LLC raised its position in shares of CytRx Corp. by 0.8% in the first quarter. Geode Capital Management LLC now owns 351,694 shares of the company’s stock worth $942,000 after buying an additional 2,958 shares during the last quarter. Hedge funds and other institutional investors own 19.60% of the company’s stock.

CytRx Corp. Company Profile

Related posts

Leave a Comment